Zydus Lifesciences Ltd.
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Public
- Established
- 1952-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.zyduscadila.com
Clinical Trials
8
Active:1
Completed:1
Trial Phases
4 Phases
Phase 1:3
Phase 3:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (42.9%)Not Applicable
2 (28.6%)Phase 3
1 (14.3%)Phase 4
1 (14.3%)Efficacy of ferrous ascorbate versus ferrous sulfate and ferrous fumarate in women with iron-deficiency anemia in pregnancy: a multi-centre randomized controlled trial
Phase 3
Not yet recruiting
- Conditions
- Iron deficiency anaemia in pregnancy
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Zydus Lifesciences Ltd.
- Target Recruit Count
- 396
- Registration Number
- SLCTR/2023/018
News
US Court Allows Lupin and Zydus to Expand Patent Defense Arguments in Myrbetriq Generic Drug Case
A US court has permitted Lupin Ltd. and Zydus Lifesciences Ltd. to expand their patent argument scope in their defense against Astellas Pharma's Myrbetriq patent litigation.